2010 Press Releases

May 20, 2010 Wockhardt's 15 months Sales stood at Rs. 4,501 crores and Operating Profit at Rs. 823 crores
May 15, 2010 Purdue University confers Habil Khorakiwala an honorary doctorate in Pharmacy
April 28, 2010 Wockhardt launches Prostate drug Tamsulosin capsules in the United States
January 25, 2010 Wockhardt's Q4 Results 2009
January 13, 2010 Wockhardt receives US FDA approval for antibacterial Levofloxacin
January 06, 2010 Wockhardt receives US FDA approval for Alzheimer's drug Memantine

2009 Press Releases

November 18, 2009 Wockhardt launches anti-hypertensive drug Nicardipine injections in USA
October 31, 2009 Wockhardt's Q3 Results 2009
October 01, 2009 Wockhardt receives US FDA approval for Prostate drug Alfuzosin tablets
September 29, 2009 Wockhardt receives US FDA approval for Prostate drug Tamsulosin capsules
July 30, 2009 Wockhardt’s Q2 Results 2009
April 24, 2009 Wockhardt’s 2008 Annual Results
February 26, 2009 Wockhardt to launch generic version of ulcer drug Ranitidine syrup in the US market
February 12, 2009 Wockhardt to launch Leveiracetam, a generic version of epilepsy drug in the US market
February 11, 2009 Wockhardt to launch Divalproex ER in the US market

2008 Press Releases

December 4, 2008 Wockhardt receives US FDA approval for generic version of Augmentin* Suspension
November 13, 2008 Wockhardt launches Midazolam in the US market
October 21, 2008 Wockhardt’s Q3 Results 2008
October 16, 2008 Wockhardt gets US FDA nod to market Ceftazidime injections
July 28, 2008 Wockhardt’s Q2 Results 2008
April 28, 2008 Wockhardt’s Q1 Results 2008
February 13, 2008 Wockhardt enters the US market with generic version of Zithromax
January 9, 2008 Wockhardt to launch generic version of anti-depressant Zoloft in the US Market
January 1, 2008 Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US

2007 Press Releases

October 27, 2007 Wockhardt acquires Morton Grove in the US
September 18, 2007 Wockhardt gets US FDA nod to enter the US$ 2.6 billion Norvasc market
July 09, 2007 Wockhardt to launch anti-epileptic injection, Fosphenytoin, in the US
June 20, 2007 Wockhardt to launch Cefprozil in the US
June 06, 2007 Wockhardt gets US FDA nod to enter the $680 million Lamisil market
  2009, Wockhardt USA, All Rights Reserved
Legal Disclaimer    |    Terms of Use    |    Privacy Policy